Pharmacological treatments for paraphilic patients and sexual offenders

Current Opinion in Psychiatry

Volumn 20, Issue 6, 2007, Pages 609-613

  Briken, Peer ^a   Kafka, Martin P ^b,c  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MCLEAN HOSPITAL   (United States)

Author keywords

Paraphilia; Pharmacotherapy; Serotonin reuptake inhibitor; Sexual offender; Testosterone

Indexed keywords

ANTIANDROGEN; CYPROTERONE; GONADORELIN AGONIST; LAMOTRIGINE; MEDROXYPROGESTERONE; MOOD STABILIZER; NALTREXONE; OPIATE ANTAGONIST; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; TESTOSTERONE; CYPROTERONE ACETATE;

ANXIETY; ATTENTION DEFICIT DISORDER; COGNITIVE THERAPY; COMORBIDITY; DEPRESSION; DIABETES MELLITUS; FOLLOW UP; GALLSTONE; GYNECOMASTIA; HOT FLUSH; HUMAN; IMPULSIVENESS; MOOD DISORDER; OSTEOPOROSIS; OUTCOME ASSESSMENT; PSYCHOTHERAPY; REVIEW; SEXUAL CRIME; SEXUAL DEVIATION; SIDE EFFECT; STANDARDIZATION; THROMBOEMBOLISM; TREATMENT OUTCOME; WEIGHT GAIN; DRUG ANTAGONISM; MALE; PSYCHOLOGICAL ASPECT;

ANDROGEN ANTAGONISTS; CYPROTERONE ACETATE; HUMANS; MALE; MEDROXYPROGESTERONE; PARAPHILIAS; SEROTONIN UPTAKE INHIBITORS; SEX OFFENSES; TESTOSTERONE;

EID: 35148889109     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/YCO.0b013e3282f0eb0b     Document Type: Review

References (42)

1. Lösel F, Schmucker M. The effectiveness of treatment for sexual offenders: a comprehensive meta-analysis. J Exp Criminol 2005; 1:117-146.
2. Hanson RK, Bussiere MT. Predicting relapse: a meta-analysis of sexual offender recidivism studies. J Consult Clin Psychol 1998; 66:348-362.
3. Maletzky BM, Tolan A, McFarland B. The Oregon depo-Provera Program: a five-year follow-up. Sex Abuse 2006; 18:303-316. This interesting study with a large population includes a scale to determine salient clinical and risk factors that favour the selection for MPA.
4. Hanson RK, Morton-Bourgon KE. The characteristics of persistent sexual offenders: a meta-analysis of recidivism studies. J Consult Clin Psychol 2005; 73:1154-1163.
5. Briken P, Hill A, Berner W. Pharmacotherapy of paraphilias with long-acting agonists of luteinizing hormone-releasing hormone: a systematic review. J Clin Psychiatry 2003; 64:890-897.
6. Schober JM, Kuhn PJ, Kovacs PG, et al. Leuprolide acetate suppresses pedophilic urges and arousability. Arch Sex Behav 2005; 34:691-705.
7. Kafka MP. A monoamine hypothesis for the pathophysiology of paraphilic disorders. Arch Sex Behav 1997; 26:337-352.
8. Kafka MP. The monoamine hypothesis for the pathophysiology of paraphilic disorders: an update. In: Prentky R, Janus E, Seto M, Burgess AW, editors. Sexually coercive behavior: understanding and management. New York: New York Academy of Sciences; 2003. pp. 86-94.
9. Kafka MP, Coleman E. Serotonin and paraphilias: the convergence of mood, impulse and compulsive disorders (letter). J Clin Psychopharmacol 1991; 11:223-224.
10. Bradford JMW. The neurobiology, neuropharmacology, and pharmacological treatment of paraphilias and compulsive sexual behavior. Can J Psychiatry 2001; 46:26-33.
11. McGrath RJ, Cummings GF, Burchard BL. Current practices and trends in sexual abuser management: the safer society 2002 national survey. Brandon, VT: Safer Society Foundation Inc; 2003.
12. Federoff JP. Antiandrogens vs. serotonergic medications in the treatment of sex offenders: a preliminary compliance study. Can J Hum Sexuality 1995; 4:111-122.
13. Lichter DG, Cummings JL. Frontal-subcortical circuits in psychiatric and neurological disorders. New York, NY: Guilford Press; 2001.
14. Kafka MP, Prentky RA. Preliminary observations of DSM III-R axis I comorbidity in men with paraphilias and paraphilia-related disorders. J Clin Psychiatry 1994; 55:481-487.
15. Kafka MP, Prentky RA. Attention deficit hyperactivity disorder in males with paraphilias and paraphilia-related disorders: a comorbidity study. J Clin Psychiatry 1998; 59:388-396.
16. Kafka MP, Hennen J. A DSM IV axis I comorbidity study of males (n=120) with paraphilias and paraphilia-related disorders. Sex Abuse 2002; 14:349-366.
17. Weiss D. The prevalence of depression in male sex addicts residing in the United States. Sex Addict Compuls 2004; 11:57-69.
18. Black DW. Compulsive sexual behavior: a review. J Pract Psychiatry Behav Health 1998; 4:217-229.
19. Galli V, McElroy SL, Soutello CA, et al. The psychiatric diagnoses of twenty two adolescents who have sexually molested other children. Comp Psychiatr 1999; 40:85-87.
20. Dunsieth NW, Nelson EB, Brusman-Lovins LA, et al. Psychiatric and legal features of 113 men convicted of sexual offenses. J Clin Psychiatry 2004; 65:293-300.
21. Vaih-Koch SR, Bosinski HAG. Childhood attention deficit hyperactivity disorder and conduct disorder in 121 sex offenders. In: Proceedings of the Twenty Fifth Annual Meeting of the International Academy of Sex Research; 23-26 June 1999; Stony Brook, New York. New Brunswick, Canada: International Academy of Sex Research; 1999.
22. Raymond NC, Coleman E, Ohlerking F, et al. Psychiatric comorbidity in pedophilic sex offenders. Am J Psychiatry 1999; 156:786-788.
23. Langstrom N, Sjostedt G, Grann M. Psychiatric disorders and recidivism in sexual offenders. Sex Abuse 2004; 16:139-150.
24. Grant JE. Clinical characteristics and psychiatric comorbidity in males with exhibitionism. J Clin Psychiatry 2005; 66:1367-1371.
25. Almeyer S, Kleinsasser D, Stoner J, Retzlaff P. Psychopathology of incarcerated sex offenders. J Personality Dis 2003; 17:306-318.
26. Raymond NC, Coleman E, Miner MH. Psychiatric comorbidity and compulsive/impulsive traits in compulsive sexual behavior. Compr Psychiatry 2003; 44:370-380.
27. McElroy SL, Soutello CA, Taylor P, et al. Psychiatric features of 36 convicted sexual offenses. J Clin Psychiatry 1999; 60:414-420.
28. Kavoussi RJ, Kaplan M, Becker JV. Psychiatric diagnoses in adolescent sex offenders. J Am Acad Child Adolesc Psychiatry 1988; 27:241-243.
29. Allnut SH, Bradford JM, Greenberg DM, Curry S. Co-morbidity of alcoholism and the paraphilias. J Forensic Sci 1996; 41:234-239.
30. Hoyer J, Kunst H, Schmidt A. Social phobia as a comorbid condition in sex offenders with paraphilia or impulse control disorder. J Nerv Ment Dis 2001; 189:463-470.
31. Eher R, Neuwirth W, Fruehwald S, Frottier P. Sexualization and lifetime impulsivity: clinically valid discriminators in sexual offenders. Int J Offender Ther Compar Criminol 2003; 47:452-467.
32. Fago DP. Comorbidity of attention deficit hyperactivity disorder in sexually aggressive children and adolescents. In: Schwartz B, editor. The sex offender: theoretical advances, treating special populations and legal developments. Kingston, New Jersey: Civic Research Institute; 1999. pp. 16.1-16.5.
33. Blanchard R, Kuban ME, Klassen P, et al. Self-reported injuries before and after age 13 in pedophilic and nonpedophilic men referred for clinical assessment. Arch Sex Behav 2003; 32:573-581.
34. Briken P, Habermann N, Berner W, Hill A. The influence of brain abnormalities on psychosocial development, criminal history and paraphilias in sexual murderers. J Forensic Sci 2005; 50:1204-1208.
35. Adi Y, Ashcroft D, Browne K, et al. Clinical effectiveness and cost-consequences of selective serotonin reuptake inhibitors in the treatment of sex offenders. Health Technol Assess 2002; 6:1-66.
36. Kraus C, Strohm K, Hill A, et al. Selective serotonin reuptake inhibitors (SSRI) in the treatment of paraphilia: a retrospective study [in German]. Fortschr Neurol Psychiat 2007; 75:351-356. This study of selective SRI treatment in paraphilic sexual offenders, although retrospective, is relevant because of the length of follow up and its inclusion of sexual side effects and subjective satisfaction of the patients.
37. Bartova D, Nahanek D. A comparative study of prophylactic lithium and diethylstilbesterol in sexual deviants. Activ Nerv Sup (Praha) 1979; 21: 163-164.
38. Bartova D, Nahunek K, Svestka J. Pharmacological treatment of deviant sexual behavior. Activ Nerv Sup (Praha) 1978; 20:72-74.
39. Kafka MP, Hennen J. Psychostimulant augmentation during treatment with selective serotonin reuptake inhibitors in males with paraphilias and paraphilia-related disorders: a case series. J Clin Psychiatry 2000; 61:664-670.
40. Raymond N, Grant JE, Kim SW, Coleman E. Treatment of compulsive sexual behavior with naltrexone and serotonin reuptake inhibitors: two case studies. Int J Psychopharmacol 2002; 17:201-205.
41. Sandyk R. Naltrexone suppresses abnormal sexual behavior in Tourette's syndrome. Int J Neurosci 1988; 43:107-110.
42. Ryback RS. Naltrexone in the treatment of adolescent sexual offenders. J Clin Psychiatry 2004; 65:982-986.